Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors
Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in ...
Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in ...
Markets regulator Sebi has asked Religare Enterprises to apply for approvals to let the billionaire Burman family buy more shares ...
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee. The ...
Pfizer’s first FDA-approved gene therapy is the second such treatment for the inherited bleeding disorder hemophilia B, introducing some competition ...
(Reuters) -Ukrainian President Volodymyr Zelenskiy expressed gratitude on Saturday for the passage by the U.S. House of Representatives of a ...
A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approval as a ...
beast01 At a Glance Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has "closed the gap" following my last update and "Buy" recommendation in ...
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.